Sundrug (9989.T) Earnings Analysis

Sundrug (9989.T) next reports earnings on 2026-08-14, consensus EPS 69.47 JPY. Last quarter (2026-05-15) it beat with EPS 61.28 JPY vs -138.57584 JPY est (+144.2%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E 14.07.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 9989.T next report earnings?

Next earnings date2026-08-14
Consensus EPS estimate69.47 JPY
Revenue estimate217.01B

9989.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-1561.28 JPY-138.57584 JPY+144.2%Beat
2026-02-1276.61 JPY83.2 JPY-7.9%Miss
2025-11-1462.62 JPY60.19 JPY+4%Beat
2025-08-1467.92 JPY68.59 JPY-1%Miss
2025-05-1559.16 JPY58.73 JPY+0.7%Beat
2025-02-1481.73 JPY77.47 JPY+5.5%Beat
2024-11-1459.69 JPY63.42 JPY-5.9%Miss
2024-08-1462.33 JPY60.72 JPY+2.7%Beat

Beat rate: 5/8 (63%) over reported quarters with consensus data.

9989.T valuation and analyst view

Trailing P/E14.07
Trailing EPS268.35 JPY
Price / book1.54
Dividend yield3.47%
Market cap446.87B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Sundrug (9989.T)'s next earnings date?

Sundrug is next scheduled to report on 2026-08-14, with a consensus EPS estimate of 69.47 JPY and revenue estimate of 217.01B.

Did 9989.T beat earnings last quarter?

In its 2026-05-15 report, 9989.T posted EPS of 61.28 JPY versus a -138.57584 JPY estimate — a beat of 144.2%.

What is 9989.T's earnings track record?

Over the last 8 reported quarters with consensus data, 9989.T beat estimates 5 times (63%).

What is 9989.T's current P/E ratio and EPS?

9989.T trades at a trailing P/E of 14.07 on trailing EPS of 268.34668285135444 JPY.

What do analysts rate 9989.T?

9989.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.